MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jgh.16006

Медицинская библиотека · Journal of gastroenterology and hepatology · 2022

Thiopurine naivety at tacrolimus induction is a predictor of long-term remission in patients with intractable ulcerative colitis who responded to tacrolimus.

Takatsu Noritaka, Hisabe Takashi, Kishi Masahiro, Takeda Teruyuki, Yasukawa Shigeyoshi, Koga Akihiro, Kinjo Ken, Hirai Fumihito, Ueki Toshiharu, Yao Kenshi

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The short-term efficacy of tacrolimus (Tac) for steroid-dependent and steroid-resistant refractory ulcerative colitis (UC) has been demonstrated; however, its long-term outcomes have not been well documented. Thus, this study aimed to clarify the long-term outcomes of patients who achieved Tac-induced remission and identify its predictors.

METHODS

This study included patients with moderate-to-severe active UC who started receiving Tac at our hospital between July 2004 and December 2016. Short-term treatment response was assessed using the Lichtiger index 3 months after starting Tac, and responding patients were further followed up to assess long-term outcomes. The primary endpoint was the relapse-free survival after Tac-induced remission, and the secondary endpoint was the identification of factors associated with relapse after Tac-induced remission.

RESULTS

The cumulative relapse-free survival rate at 10 years after Tac-induced remission was 33.2%. Multivariate analysis revealed that being thiopurine naïve at Tac induction was associated with the absence of relapse (hazard ratio: 0.45; 95% confidence interval: 0.22-0.92).

CONCLUSIONS

Approximately one-third of patients who achieved Tac-induced remission maintained long-term remission. Being thiopurine naïve at Tac induction was a predictor of the absence of relapse.

Для цитирования: Takatsu Noritaka, Hisabe Takashi, Kishi Masahiro, Takeda Teruyuki, Yasukawa Shigeyoshi, Koga Akihiro, Kinjo Ken, Hirai Fumihito, Ueki Toshiharu, Yao Kenshi. Thiopurine naivety at tacrolimus induction is a predictor of long-term remission in patients with intractable ulcerative colitis who responded to tacrolimus.. Journal of gastroenterology and hepatology. 2022. DOI: 10.1111/jgh.16006.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.